Nonadrenergic Binding of [3H]Atipamezole in Rat Lung
Nonadrenergic Binding of [3H]Atipamezole in Rat Lung
复制标题
[3H]阿替帕唑在大鼠肺中的非肾上腺素结合
DOI:
10.1111/j.1749-6632.1995.tb32391.x
复制
发表时间:
1995
影响因子:
5.2
通讯作者:
M. Scheinin
中科院分区:
文献类型:
--
作者:
B. Sjöholm;J. Savola;M. Scheinin
Both [3H] idazoxan and [3H] para-aminoclonidine were initially thought to be selective radioligands for a,-adrenoceptors. However, they were subsequently also shown to bind extensively to nonadrenergic imidazoline binding sites in brain and other tissues. 1-5 Imidazoline-preferring binding sites or receptors were proposed to mediate the central antihypertensive6 and in~ ulin-increasing~.~ actions of some imidazolines. These nonadrenergic binding sites may also mediate neuroprotective effects in an experimental stroke model.'Imidazoline receptors may also participate in the contraction of vascular and other smooth Human blood platelets have nonadrenergic para-aminoclonidine binding sites that ma be involved in platelet aggregation. 12 Their density may be increased in depression. Imidazoline-preferring receptors have been divided into several subclasses which differ from each other with respect to their relative affinities for 1igat1ds. I~ One, the I,-receptor, preferentially binds clonidine and para-aminoclonidine, is localized to plasma membranes, and has limited tissue distribution. I,-receptors preferentially bind idazoxan and are present in a number of tissues and cell types. 1,-receptors may be further subdivided into I, and I,, types by the binding affinities of, for example, phentolamine and amiloride.Studies with subcellular fractions from human and rabbit liver have demonstrated that [3H] idazoxan binding to I,, sites is localized to mitochondrial fractions. l5 Blood platelets have I,,-type binding sites in their internal membranes. l6 Therefore, in contrast to a,-adrenoceptor binding, which is localized to the plasma membrane,[3H] idazoxan binding to I2 sites appears to be located intracellularly at least in liver cells and blood platelets.
登录
查看更多内容
DOI:
--
发表时间:
1991
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Blaxall,HS;Murphy,TJ;Baker,JC;Ray,C;Bylund,DB
通讯作者:
Bylund,DB
DOI:
--
发表时间:
1988
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Bylund,DB;Ray-Prenger,C;Murphy,TJ
通讯作者:
Murphy,TJ
影响因子:
56.9
作者:
LI, G;REGUNATHAN, S;REIS, DJ
通讯作者:
REIS, DJ
DOI:
--
发表时间:
1989
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Parini,A;Coupry,I;Graham,RM;Uzielli,I;Atlas,D;Lanier,SM
通讯作者:
Lanier,SM
影响因子:
--
作者:
Piletz,JE;Halaris,A;Saran,A;Marler,MR
通讯作者:
Marler,MR